OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
An expanded universe of cancer targets
William C. Hahn, Joel S. Bader, Theodore P. Braun, et al.
Cell (2021) Vol. 184, Iss. 5, pp. 1142-1155
Open Access | Times Cited: 179
William C. Hahn, Joel S. Bader, Theodore P. Braun, et al.
Cell (2021) Vol. 184, Iss. 5, pp. 1142-1155
Open Access | Times Cited: 179
Showing 1-25 of 179 citing articles:
Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer
Srivatsan Raghavan, Peter Winter, Andrew W. Navia, et al.
Cell (2021) Vol. 184, Iss. 25, pp. 6119-6137.e26
Open Access | Times Cited: 343
Srivatsan Raghavan, Peter Winter, Andrew W. Navia, et al.
Cell (2021) Vol. 184, Iss. 25, pp. 6119-6137.e26
Open Access | Times Cited: 343
Signalling mechanisms and cellular functions of SUMO
Alfred C.O. Vertegaal
Nature Reviews Molecular Cell Biology (2022) Vol. 23, Iss. 11, pp. 715-731
Closed Access | Times Cited: 201
Alfred C.O. Vertegaal
Nature Reviews Molecular Cell Biology (2022) Vol. 23, Iss. 11, pp. 715-731
Closed Access | Times Cited: 201
Single-cell meta-analyses reveal responses of tumor-reactive CXCL13+ T cells to immune-checkpoint blockade
Baolin Liu, Yuanyuan Zhang, Dongfang Wang, et al.
Nature Cancer (2022) Vol. 3, Iss. 9, pp. 1123-1136
Closed Access | Times Cited: 167
Baolin Liu, Yuanyuan Zhang, Dongfang Wang, et al.
Nature Cancer (2022) Vol. 3, Iss. 9, pp. 1123-1136
Closed Access | Times Cited: 167
Molecular Characterization ofKRASWild-type Tumors in Patients with Pancreatic Adenocarcinoma
Philip A. Philip, Ibrahim Azar, Joanne Xiu, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 12, pp. 2704-2714
Open Access | Times Cited: 117
Philip A. Philip, Ibrahim Azar, Joanne Xiu, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 12, pp. 2704-2714
Open Access | Times Cited: 117
Small molecule inhibitors targeting the cancers
Guihong Liu, Tao Chen, Xin Zhang, et al.
MedComm (2022) Vol. 3, Iss. 4
Open Access | Times Cited: 87
Guihong Liu, Tao Chen, Xin Zhang, et al.
MedComm (2022) Vol. 3, Iss. 4
Open Access | Times Cited: 87
Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study
Hanmin Wang, Chan-Yuan Zhang, Kai‐Cheng Peng, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 2, pp. 100911-100911
Open Access | Times Cited: 87
Hanmin Wang, Chan-Yuan Zhang, Kai‐Cheng Peng, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 2, pp. 100911-100911
Open Access | Times Cited: 87
Towards precision oncology with patient-derived xenografts
Eugenia R. Zanella, Elena Grassi, Livio Trusolino
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 11, pp. 719-732
Closed Access | Times Cited: 84
Eugenia R. Zanella, Elena Grassi, Livio Trusolino
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 11, pp. 719-732
Closed Access | Times Cited: 84
The NCI-MATCH trial: lessons for precision oncology
Peter J. O’Dwyer, Robert J. Gray, Keith T. Flaherty, et al.
Nature Medicine (2023) Vol. 29, Iss. 6, pp. 1349-1357
Closed Access | Times Cited: 80
Peter J. O’Dwyer, Robert J. Gray, Keith T. Flaherty, et al.
Nature Medicine (2023) Vol. 29, Iss. 6, pp. 1349-1357
Closed Access | Times Cited: 80
Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives
Hao Lin, Chaxian Liu, An-Kang Hu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 59
Hao Lin, Chaxian Liu, An-Kang Hu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 59
The impact of lipid metabolism on breast cancer: a review about its role in tumorigenesis and immune escape
Diandra Zipinotti dos Santos, Josiany Carlos de Souza, Tatiana Massariol Pimenta, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 55
Diandra Zipinotti dos Santos, Josiany Carlos de Souza, Tatiana Massariol Pimenta, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 55
A new wave of innovations within the DNA damage response
Qi Li, Wenyuan Qian, Yang Zhang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 50
Qi Li, Wenyuan Qian, Yang Zhang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 50
DrugMap: A quantitative pan-cancer analysis of cysteine ligandability
Mariko Takahashi, Harrison B. Chong, Siwen Zhang, et al.
Cell (2024) Vol. 187, Iss. 10, pp. 2536-2556.e30
Open Access | Times Cited: 20
Mariko Takahashi, Harrison B. Chong, Siwen Zhang, et al.
Cell (2024) Vol. 187, Iss. 10, pp. 2536-2556.e30
Open Access | Times Cited: 20
Macrocycles and macrocyclization in anticancer drug discovery: Important pieces of the puzzle
Chao Zhang, Fenfen Liu, You‐Ming Zhang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116234-116234
Closed Access | Times Cited: 18
Chao Zhang, Fenfen Liu, You‐Ming Zhang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116234-116234
Closed Access | Times Cited: 18
Decoding the functional impact of the cancer genome through protein–protein interactions
Haian Fu, Xiulei Mo, Andrei A. Ivanov
Nature reviews. Cancer (2025)
Closed Access | Times Cited: 2
Haian Fu, Xiulei Mo, Andrei A. Ivanov
Nature reviews. Cancer (2025)
Closed Access | Times Cited: 2
A histidine cluster determines YY1-compartmentalized coactivators and chromatin elements in phase-separated enhancer clusters
Wenmeng Wang, Shiyao Qiao, Guangyue Li, et al.
Nucleic Acids Research (2022) Vol. 50, Iss. 9, pp. 4917-4937
Open Access | Times Cited: 57
Wenmeng Wang, Shiyao Qiao, Guangyue Li, et al.
Nucleic Acids Research (2022) Vol. 50, Iss. 9, pp. 4917-4937
Open Access | Times Cited: 57
VB12-Sericin-PBLG-IR780 Nanomicelles for Programming Cell Pyroptosis via Photothermal (PTT)/Photodynamic (PDT) Effect-Induced Mitochondrial DNA (mitoDNA) Oxidative Damage
Weihong Guo, Zhenhao Li, Huilin Huang, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 15, pp. 17008-17021
Closed Access | Times Cited: 47
Weihong Guo, Zhenhao Li, Huilin Huang, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 15, pp. 17008-17021
Closed Access | Times Cited: 47
Systematic discovery of mutation-directed neo-protein-protein interactions in cancer
Xiulei Mo, Qiankun Niu, Andrei A. Ivanov, et al.
Cell (2022) Vol. 185, Iss. 11, pp. 1974-1985.e12
Open Access | Times Cited: 42
Xiulei Mo, Qiankun Niu, Andrei A. Ivanov, et al.
Cell (2022) Vol. 185, Iss. 11, pp. 1974-1985.e12
Open Access | Times Cited: 42
Crucial roles of circulating tumor cells in the metastatic cascade and tumor immune escape: biology and clinical translation
Klaus Pantel, Catherine Alix‐Panabières
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 12, pp. e005615-e005615
Open Access | Times Cited: 42
Klaus Pantel, Catherine Alix‐Panabières
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 12, pp. e005615-e005615
Open Access | Times Cited: 42
Therapeutic Strategies for Targeting CDKN2A Loss in Melanoma
Inger Z. M. Kreuger, Roderick C. Slieker, Tim van Groningen, et al.
Journal of Investigative Dermatology (2022) Vol. 143, Iss. 1, pp. 18-25.e1
Open Access | Times Cited: 38
Inger Z. M. Kreuger, Roderick C. Slieker, Tim van Groningen, et al.
Journal of Investigative Dermatology (2022) Vol. 143, Iss. 1, pp. 18-25.e1
Open Access | Times Cited: 38
A Ubiquitination Cascade Regulating the Integrated Stress Response and Survival in Carcinomas
Lisa D. Cervia, Tsukasa Shibue, Ashir A. Borah, et al.
Cancer Discovery (2022) Vol. 13, Iss. 3, pp. 766-795
Open Access | Times Cited: 38
Lisa D. Cervia, Tsukasa Shibue, Ashir A. Borah, et al.
Cancer Discovery (2022) Vol. 13, Iss. 3, pp. 766-795
Open Access | Times Cited: 38
Cancer Evolution: A Multifaceted Affair
Giovanni Ciriello, Luca Magnani, Sarah J. Aitken, et al.
Cancer Discovery (2023) Vol. 14, Iss. 1, pp. 36-48
Open Access | Times Cited: 26
Giovanni Ciriello, Luca Magnani, Sarah J. Aitken, et al.
Cancer Discovery (2023) Vol. 14, Iss. 1, pp. 36-48
Open Access | Times Cited: 26
A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies
Prabhjot S. Mundi, Filemon S. Dela Cruz, Adina Grunn, et al.
Cancer Discovery (2023) Vol. 13, Iss. 6, pp. 1386-1407
Open Access | Times Cited: 22
Prabhjot S. Mundi, Filemon S. Dela Cruz, Adina Grunn, et al.
Cancer Discovery (2023) Vol. 13, Iss. 6, pp. 1386-1407
Open Access | Times Cited: 22
scRank infers drug-responsive cell types from untreated scRNA-seq data using a target-perturbed gene regulatory network
Chengyu Li, Xin Shao, Shujing Zhang, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 6, pp. 101568-101568
Open Access | Times Cited: 10
Chengyu Li, Xin Shao, Shujing Zhang, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 6, pp. 101568-101568
Open Access | Times Cited: 10
METTL4-mediated nuclear N6-deoxyadenosine methylation promotes metastasis through activating multiple metastasis-inducing targets
Kai‐Wen Hsu, Joseph Chieh‐Yu Lai, Jeng‐Shou Chang, et al.
Genome biology (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 34
Kai‐Wen Hsu, Joseph Chieh‐Yu Lai, Jeng‐Shou Chang, et al.
Genome biology (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 34
Immune cellular components and signaling pathways in the tumor microenvironment
Sasitorn Yenyuwadee, Konstantinos Aliazis, Qi Wang, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 187-201
Open Access | Times Cited: 33
Sasitorn Yenyuwadee, Konstantinos Aliazis, Qi Wang, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 187-201
Open Access | Times Cited: 33
